Funding antiretroviral treatment for HIV-positive temporary residents in Australia prevents transmission and is inexpensive

Por Gray, Richard T., Watson, Jo, Cogle, Aaron J., Smith, Don E., Hoy, Jennifer F., Bastian, Lisa A., Finlayson, Robert, Drummond, Fraser M., Whittaker, Bill, Law, Matthew G., Petoumenos, Kathy
Publicado no Sex Health (2018)

Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer

Por Awasthi, Niranjan, Zhang, Changhua, Schwarz, Anna M., Hinz, Stefan, Wang, Changguang, Williams, Noelle S., Schwarz, Margaret A., Schwarz, Roderich E.
Publicado em 2013

Enhancement of Nab-Paclitaxel Antitumor Activity through Addition of Multitargeting Antiangiogenic Agents in Experimental Pancreatic Cancer

Por Awasthi, Niranjan, Zhang, Changhua, Schwarz, Anna M., Hinz, Stefan, Schwarz, Margaret A., Schwarz, Roderich E.
Publicado no Mol Cancer Ther (2014)

The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer

Por ZHANG, CHANG-HUA, AWASTHI, NIRANJAN, SCHWARZ, MARGARET A., SCHWARZ, RODERICH E.
Publicado em 2013

Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models

Por Awasthi, Niranjan, Scire, Emily, Monahan, Sheena, Grojean, Meghan, Zhang, Eric, Schwarz, Margaret A., Schwarz, Roderich E.
Publicado no Oncotarget (2016)

A tolerability assessment of new respiratory protective devices developed for health care personnel: A randomized simulated clinical study

Por Radonovich, Lewis J., Wizner, Kerri, LaVela, Sherri L., Lee, Martin L., Findley, Kimberly, Yorio, Patrick
Publicado no PLoS One (2019)

Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma

Por Azzariti A, Brunetti O, Porcelli L, Graziano G, Iacobazzi RM, Signorile M, Scarpa A, Lorusso V, Silvestris N
Publicado em 2016-07-01

COMPARATIVE EVALUATION OF THE LONG-TERM EFFICACY AND SAFETY OF THE INFLIXIMAB BIOSIMILAR BCD-055...

Por A. M. Lila, V. I. Mazurov, E. V. Zonova, O. B. Nesmeyanova, T. V. Plaksina, D. G. Krechikova, O. V. Reshet’ko, L. N. Denisov, I. G. Gordeev, T. G. Pokrovskaya, O. V. Antipova, T. V. Kropotina, T. V. Povarova, P. A. Shesternya, E. N. Ushakova, N. F. Soroka, E. V. Kunder, A. V. Eremeeva, E. V. Chernyaeva, R. A. Ivanov, P. S. Pukhtinskaya
Publicado em 2018-07-01

Pharmacovigilance in pharmaceutical companies: An overview

Por Mammì, Maria, Citraro, Rita, Torcasio, Giovanni, Cusato, Gennaro, Palleria, Caterina, di Paola, Eugenio Donato
Publicado em 2013

The Burden of Silicosis in Michigan: 1988–2016

Por Reilly, Mary Jo, Timmer, Suzanne J., Rosenman, Kenneth D.
Publicado no Ann Am Thorac Soc (2018)

Genetic Testing Integration Panels (GTIPs): A novel approach for considering integration of direct-to-consumer and other new genetic tests into patient care

Por Uhlmann, Wendy R., Sharp, Richard R.
Publicado em 2012

Conflict of interest in Health Technology Assessment decisions: case law in France and impact on reimbursement decisions

Por Frybourg, Sandrine, Remuzat, Cécile, Kornfeld, Åsa, Toumi, Mondher
Publicado no J Mark Access Health Policy (2015)

Patient Autonomy in Direct Primary Care

Por Sara Gottesman
Publicado em 2022-05-01

Development of a Stable MGAT1(−) CHO Cell Line to Produce Clade C gp120 With Improved Binding to Broadly Neutralizing Antibodies

Por Doran, Rachel C., Yu, Bin, Wright, Meredith, O'Rourke, Sara M., Yin, Lu, Richardson, Jennie M., Byrne, Gabriel, Mesa, Kathryn A., Berman, Phillip W.
Publicado no Front Immunol (2018)

Insurance coverage for male infertility care in the United States

Por Dupree, James M
Publicado no Asian J Androl (2016)

Frontiers of Real Estate Science in Japan

Publicado no New Frontiers in Regional Science: Asian Perspectives (2021)

Proceedings of the 2013 CINP Summit: Innovative Partnerships to Accelerate CNS Drug Discovery for Improved Patient Care

Por Phillips, Anthony George, Hongaard-Andersen, Peter, Moscicki, Richard A., Sahakian, Barbara, Quirion, Rémi, Krishnan, K. Ranga Rama, Race, Tim
Publicado no Int J Neuropsychopharmacol (2015)

Methodological approach to determine minor, considerable, and major treatment effects in the early benefit assessment of new drugs

Por Skipka, Guido, Wieseler, Beate, Kaiser, Thomas, Thomas, Stefanie, Bender, Ralf, Windeler, Jürgen, Lange, Stefan
Publicado no Biom J (2016)

NETWORKED 3B: a novel protein in the actin cytoskeleton-endoplasmic reticulum interaction

Por Wang, Pengwei, Hussey, Patrick J
Publicado no J Exp Bot (2017)

A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance)

Por Rashkin, Sara R., Chua, Katherina C., Ho, Carol, Mulkey, Flora, Jiang, Chen, Mushiroda, Tasei, Kubo, Michiaki, Friedman, Paula N., Rugo, Hope S., McLeod, Howard L., Ratain, Mark J., Castillos, Francisco, Naughton, Michael, Overmoyer, Beth, Toppmeyer, Deborah, Witte, John S., Owzar, Kouros, Kroetz, Deanna L.
Publicado no Clin Pharmacol Ther (2018)